The number of regulatory Foxp3+ T-cells in different stages of malignant transformation of large intestinal polyps

2016 ◽  
Vol 61 (2) ◽  
pp. 306-310 ◽  
Author(s):  
Mateusz Rubinkiewicz ◽  
Marcin Migaczewski ◽  
Jerzy Hankus ◽  
Marcin Dembiński ◽  
Michał Pędziwiatr ◽  
...  
2017 ◽  
Vol 63 (1) ◽  
pp. 13-26 ◽  
Author(s):  
D.D. Zhdanov ◽  
D.A. Vasina ◽  
E.V. Orlova ◽  
V.S. Orlova ◽  
V.S. Pokrovsky ◽  
...  

Alternative splicing of telomerase catalytic subunit hTERT pre-mRNA (human Telomerase Reverse Transcriptase) regulates telomerase activity. Increased expression of non-active splice variant hTERT results in inhibition of telomerase. Apoptotic endonuclease EndoG is known to participate in hTERT alternative splicing. Expression of EndoG can be induced in response to DNA damages. The aim of this study was to determine the ability of a DNA-damaging compound, cisplatin, to induce EndoG and its influence on alternative splicing of hTERT and telomerase activity in human CD4+ Т lymphocytes. Overexpression of EndoG in CD4+ T cells downregulated the expression of active full-length hTERT variant and upregulated its non-active spliced variant. Reduction of full-length hTERT caused downregulation of telomerase activity, shortening of telomeres length during cell divisions, converting cells to the replicative senescence state, activation of apoptosis and finally cell death. Few cells survived and underwent malignant transformation. Transformed cells have increased telomerase activity and proliferative potential compare to initial CD4+ T cells. These cells have phenotype of T lymphoblastic leukemic cells and are able to form tumors and cause death in experimental mice.


2021 ◽  
pp. canres.2297.2020
Author(s):  
Jan M. Pawlicki ◽  
David L Cookmeyer ◽  
Damian Maseda ◽  
John K. Everett ◽  
Fang Wei ◽  
...  

2020 ◽  
Vol 11 ◽  
Author(s):  
Michiyuki Maeda ◽  
Junko Tanabe-Shibuya ◽  
Paola Miyazato ◽  
Hiroshi Masutani ◽  
Jun-ichirou Yasunaga ◽  
...  

Blood ◽  
2006 ◽  
Vol 107 (10) ◽  
pp. 3933-3939 ◽  
Author(s):  
Andreas Krueger ◽  
Stefanie C. Fas ◽  
Marco Giaisi ◽  
Marc Bleumink ◽  
Anette Merling ◽  
...  

The HTLV-1 transactivator protein Tax is essential for malignant transformation of CD4 T cells, ultimately leading to adult T-cell leukemia/lymphoma (ATL). Malignant transformation may involve development of apoptosis resistance. In this study we investigated the molecular mechanisms by which HTLV-1 Tax confers resistance toward CD95-mediated apoptosis. We show that Tax-expressing T-cell lines derived from HTLV-1–infected patients express elevated levels of c-FLIPL and c-FLIPS. The levels of c-FLIP correlated with resistance toward CD95-mediated apoptosis. Using an inducible system we demonstrated that both resistance toward CD95-mediated apoptosis and induction of c-FLIP are dependent on Tax. In addition, analysis of early cleavage of the BH3-only Bcl-2 family member Bid, a direct caspase-8 substrate, revealed that apoptosis is inhibited at a CD95 death receptor proximal level in Tax-expressing cells. Finally, using siRNA we directly showed that c-FLIP confers Tax-mediated resistance toward CD95-mediated apoptosis. In conclusion, our data suggest an important mechanism by which expression of HTLV-1 Tax may lead to immune escape of infected T cells and, thus, to persistent infection and transformation.


2019 ◽  
Vol 70 (1) ◽  
pp. 409-424 ◽  
Author(s):  
Michael A. Curran ◽  
Bonnie S. Glisson

The driver and passenger mutations accumulated in the process of malignant transformation offer an adequate spectrum of immune visible alterations to the cellular proteome and resulting peptidome to render these cancers targetable—and, in theory, rejectable—by the host T cell immune response. In addition, cancers often overexpress tissue-specific and developmental antigens to which immune tolerance is incomplete. Sometimes, virally transferred oncogenes drive malignant transformation and remain expressed throughout the cancer. Despite this state of antigenic sufficiency, cancer grows progressively and overcomes all efforts of the host immune system to contain it. While therapeutic cancer vaccination can mobilize high frequencies of tumor-specific T cells, these responses remain subject to intratumoral attenuation. Antibody modulation of T cell function through checkpoint blockade or costimulatory activation can restore survival, proliferation, and effector function to these tumor-infiltrating T cells and convert otherwise subtherapeutic vaccines into potentially curative cancer immunotherapeutics.


2017 ◽  
Vol 82 (1) ◽  
pp. 24-37 ◽  
Author(s):  
D. A. Vasina ◽  
D. D. Zhdanov ◽  
E. V. Orlova ◽  
V. S. Orlova ◽  
M. V. Pokrovskaya ◽  
...  

2018 ◽  
Vol 23 (4) ◽  
pp. 1913-1919 ◽  
Author(s):  
Aline Lauda Freitas Chaves ◽  
Ana Gabriela Silva ◽  
Flávia Medeiros Maia ◽  
Gabriela Francine Martins Lopes ◽  
Luiz Fernando Barbosa de Paulo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document